Potential role for rFVIIa in transfusion medicine
- 1 January 2002
- journal article
- review article
- Published by Wiley in Transfusion
- Vol. 42 (1), 114-124
- https://doi.org/10.1046/j.1537-2995.2002.00017.x
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- REDUCED TRANSFUSION REQUIREMENTS BY RECOMBINANT FACTOR VIIa IN ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 2001
- SUCCESSFUL USE OF RECOMBINANT FVIIa (NOVOSEVEN®) IN THE MANAGEMENT OF INTRACTABLE POST‐SURGICAL INTRA‐ABDOMINAL HAEMORRHAGEBritish Journal of Haematology, 1999
- Use of Recombinant, Activated Factor VII in the Treatment of Congenital Factor VII DeficienciesVox Sanguinis, 1999
- Determinants of Substrate Specificity for Factor XIIISeminars in Thrombosis and Hemostasis, 1996
- Native fibrin gel networks observed by 3D microscopy, permeation and turbidityBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989
- Effects of hydroxyethyl starch on blood coagulation, particularly factor VIIITransfusion, 1985
- Regulation of Extravascular Coagulation by Microvascular PermeabilityScience, 1985
- Coronary artery disease in severe haemophilia.Heart, 1983
- Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.JCI Insight, 1983
- Effect of Dextran on Factor VIII (Antihemophilic Factor) and Platelet FunctionAnnals of Surgery, 1979